Acquisition of TP53 alterations with disease progression has also been noted in various hematologic malignancies, like chronic lymphocytic leukemia [13] and multiple myeloma [14], in which it is also associated with worse outcome. The gene discussed is TP53; the disease is plasma cell myeloma.